Epidemiological And Molecular Mechanisms Aspects Linking Obesity And Cancer [mecanismos Epidemiológicos E Moleculares Que Associam Obesidade E Câncer]

About 25% of cancer cases globally are due to excess weight and a sedentary lifestyle. These results are alarming, as the world knows a pandemy of obesity and, in consequence, insulin resistance. Obesity may increase risk for various cancers by several mechanisms, including increasing sex and metabolic hormones, and inflammation. Here, we present a review of epidemiological and molecular evidences linking obesity and cancer - particularly colorectal, post-menopausal breast, endometrial, pancreatic, high grade prostate, hepatocellular, gallbladder, kidney and esophageal adenocarcinoma. The expected striking increase in the incidence of cancer in the near future related to obesity turns the knowledge of this field of great impact as it is needed to the development of strategies to prevent and treat this disease.532213226Filozof, C., Gonzalez, C., Sereday, M., Mazza, C., Braguinsky, J., Obesity prevalence and trends in Latin-American countries (2001) Obes Rev, 2 (2), pp. 99-106Carvalheira, J.B., Saad, M.J., (2006) Arq Bras Endocrinol Metabol, 50 (2), pp. 360-367. , Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome, Epub 2006 May 23, Review, Portugueseden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J., Flegal, K.M., Prevalence of overweight and obesity in the United States, 1999-2004 (2006) JAMA, 295 (13), pp. 1549-1555(2002) Weight Control and Physical Activity, , IARC - International Agency for Research on Cancer Working Group on the Evaluation of Cancer-Preventive Strategies, Lyon, France: IARC Press(2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective, , WCRF - World Cancer Reserach Fund, Washington: American Institute for Cancer ResearchReeves, G.K., Pirie, K., Beral, V., Green, J., Spencer, E., Bull, D., Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study (2007) BMJ, 335 (7634), p. 1134. , Epub 2007 Nov 6Renehan, A.G., Tyson, M., Egger, M., Heller, R.F., Zwahlen, M., Body mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies (2008) Lancet, 371 (9612), pp. 569-578. , ReviewRenehan, A.G., Roberts, D.L., Dive, C., Obesity and cancer: Pathophysiological and biological mechanisms (2008) Arch Physiol Biochem, 114 (1), pp. 71-83. , ReviewCalle, E.E., Rodriguez, C., Walker-Thurmond, K., Thun, M.J., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults (2003) N Engl J Med, 348 (17), pp. 1625-1638Yakar, S., Nunez, N.P., Pennisi, P., Brodt, P., Sun, H., Fallavollita, L., Increased tumor growth in mice with diet-induced obesity: Impact of ovarian hormones (2006) Endocrinology, 147 (12), pp. 5826-5834. , Epub 2006 Sep 7Dirx, M.J., Zeegers, M.P., Dagnelie, P.C., van den Bogaard, T., van den Brandt, P.A., Energy restriction and the risk of spontaneous mammary tumors in mice: A meta-analysis (2003) Int J Cancer, 106 (5), pp. 766-770Chow, W.H., Gridley, G., Fraumeni Jr., J.F., Järvholm, B., Obesity, hypertension, and the risk of kidney cancer in men (2000) N Engl J Med, 343 (18), pp. 1305-1311Larsson, S.C., Orsini, N., Wolk, A., Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies (2007) Int J Cancer, 120 (9), pp. 1993-1998Pischon, T., Lahmann, P.H., Boeing, H., Friedenreich, C., Norat, T., Tjønneland, A., Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC) (2006) J Natl Cancer Inst, 98 (13), pp. 920-931Jenab, M., Riboli, E., Cleveland, R.J., Norat, T., Rinaldi, S., Nieters, A., Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition (2007) Int J Cancer, 121 (2), pp. 368-376Sandhu, M.S., Dunger, D.B., Giovannucci, E.L., Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer (2002) J Natl Cancer Inst, 94 (136), pp. 972-980Renehan, A.G., Zwahlen, M., Minder, C., O'Dwyer, S.T., Shalet, S.M., Egger, M., Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis (2004) Lancet, 363 (9418), pp. 1346-1353Ma, J., Pollak, M.N., Giovannucci, E., Chan, J.M., Tao, Y., Hennekens, C.H., Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 (1999) J Natl Cancer Inst, 91 (7), pp. 620-625Wolpin, B.M., Meyerhardt, J.A., Chan, A.T., Ng, K., Chan, J.A., Wu, K., Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer (2009) J Clin Oncol, 27 (2), pp. 176-185. , Epub 2008 Dec 8Aaronson, S.A., Growth factors and cancer (1991) Science, 254 (5035), pp. 1146-1153. , ReviewKaaks, R., Lukanova, A., Energy balance and cancer: The role of insulin and insulin-like growth factor-I (2001) Proc Nutr Soc, 60 (1), pp. 91-106. , ReviewStattin, P., Lukanova, A., Biessy, C., Söderberg, S., Palmqvist, R., Kaaks, R., Obesity and colon cancer: Does leptin provide a link? (2004) Int J Cancer, 109 (1), pp. 149-152Carvalheira, J.B., Siloto, R.M., Ignacchitti, I., Brenelli, S.L., Carvalho, C.R., Leite, A., Insulin modulates leptin-induced STAT3 activation in rat hypothalamus (2001) FEBS Lett, 500 (3), pp. 119-124Björntorp, P., Obesity (1997) Lancet, 350 (9075), pp. 423-426Giovannucci, E., Colditz, G.A., Stampfer, M.J., Willett, W.C., Physical activity, obesity, and risk of colorectal adenoma in women (United States) (1996) Cancer Causes Control, 7 (2), pp. 253-263Stattin, P., Palmqvist, R., Söderberg, S., Biessy, C., Ardnor, B., Hallmans, G., Plasma leptin and colorectal cancer risk: A prospective study in Northern Sweden (2003) Oncol Rep, 10 (6), pp. 2015-2021Wei, E.K., Giovannucci, E., Fuchs, C.S., Willett, W.C., Mantzoros, C.S., Low plasma adiponectin levels and risk of colorectal cancer in men: A prospective study (2005) J Natl Cancer Inst, 97 (22), pp. 1688-1694Lukanova, A., Söderberg, S., Kaaks, R., Jellum, E., Stattin, P., Serum adiponectin is not associated with risk of colorectal cancer (2006) Cancer Epidemiol Biomarkers Prev, 15, pp. 401-402Huang, Z., Hankinson, S.E., Colditz, G.A., Stampfer, M.J., Hunter, D.J., Manson, J.E., Dual effects of weight and weight gain on breast cancer risk (1997) JAMA, 278 (17), pp. 1407-1411Travis, R.C., Key, T.J., Oestrogen exposure and breast cancer risk (2003) Breast Cancer Res, 5 (5), pp. 239-247Schairer, C., Hill, D., Sturgeon, S.R., Fears, T., Pollak, M., Mies, C., Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women (2004) Int J Cancer, 108 (5), pp. 773-779Toniolo, P., Bruning, P.F., Akhmedkhanov, A., Bonfrer, J.M., Koenig, K.L., Lukanova, A., Serum insulin-like growth factor-I and breast cancer (2000) Int J Cancer, 88 (5), pp. 828-832Yang, G., Lu, G., Jin, F., Dai, Q., Best, R., Shu, X.O., Population-based, case-control study of blood C-peptide level and breast cancer risk (2001) Cancer Epidemiol Biomarkers Prev, 10 (11), pp. 1207-1211Hirose, K., Toyama, T., Iwata, H., Takezaki, T., Hamajima, N., Tajima, K., Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women (2003) Asian Pac J Cancer Prev, 4 (3), pp. 239-246Hankinson, S.E., Willett, W.C., Colditz, G.A., Hunter, D.J., Michaud, D.S., Deroo, B., Circulating concentrations of insulin-like growth factor-I and risk of breast cancer (1998) Lancet, 351 (9113), pp. 1393-1396Goodwin, P.J., Ennis, M., Pritchard, K.I., Trudeau, M.E., Koo, J., Hartwick, W., Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes (2002) Breast Cancer Res Treat, 74 (1), pp. 65-76Vona-Davis, L., Rose, D.P., Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression (2007) Endocr Relat Cancer, 14 (2), pp. 189-206Miyoshi, Y., Funahashi, T., Kihara, S., Taguchi, T., Tamaki, Y., Matsuzawa, Y., Association of serum adiponectin levels with breast cancer risk (2003) Clin Cancer Res, 9 (15), pp. 5699-5704Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D.M., Adiponectin and breast cancer risk (2004) J Clin Endocrinol Metab, 89 (3), pp. 1102-1107Kaaks, R., Lukanova, A., Kurzer, M.S., Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review (2002) Cancer Epidemiol Biomarkers Prev, 11 (12), pp. 1531-1543. , ReviewLukanova, A., Lundin, E., Micheli, A., Arslan, A., Ferrari, P., Rinaldi, S., Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women (2004) Int J Cancer, 108 (3), pp. 425-432Lukanova, A., Zeleniuch-Jacquotte, A., Lundin, E., Micheli, A., Arslan, A.A., Rinaldi, S., Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer (2004) Int J Cancer, 108 (2), pp. 262-268Nicodemus, K.K., Sweeney, C., Folsom, A.R., Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women (2004) Int J Cancer, 108 (1), pp. 115-121Bergstrom, A., Hsieh, C.C., Lindblad, P., Lu, C.M., Cook, N.R., Wolk, A., Obesity and renal cell cancer-a quantitative review (2001) Br J Cancer, 85 (7), pp. 984-990Pischon, T., Lahmann, P.H., Boeing, H., Tjonneland, A., Halkjaer, J., Overvad, K., Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) (2006) Int J Cancer, 118 (3), pp. 728-738Lindblad, P., Chow, W.H., Chan, J., Bergström, A., Wolk, A., Gridley, G., The role of diabetes mellitus in the aetiology of renal cell cancer (1999) Diabetologia, 42 (1), pp. 107-112Spyridopoulos, T.N., Petridou, E.T., Skalkidou, A., Dessypris, N., Chrousos, G.P., Mantzoros, C.S., Low adiponectin levels are associated with renal cell carcinoma: A case-control study (2007) Int J Cancer, 120 (7), pp. 1573-1578Pera, M., Manterola, C., Vidal, O., Grande, L., Epidemiology of esophageal adenocarcinoma (2005) J Surg Oncol, 92 (3), pp. 151-159Kubo, A., Corley, D.A., Body mass index and adenocarcinomas of the esophagus or gastric cardia: A systematic review and metaanalysis (2006) Cancer Epidemiol Biomarkers Prev, 15 (5), pp. 872-878Abnet, C.C., Freedman, N.D., Hollenbeck, A.R., Fraumeni Jr., J.F., Leitzmann, M., Schatzkin, A., A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma (2008) Eur J Cancer, 44 (3), pp. 465-471Corley, D.A., Kubo, A., Zhao, W., Abdominal obesity and the risk of esophageal and gastric cardia carcinomas (2008) Cancer Epidemiol Biomarkers Prev, 17 (2), pp. 352-358Hampel, H., Abraham, N.S., El-Serag, H.B., Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications (2005) Ann Intern Med, 143 (3), pp. 199-211Giovannucci, E., Michaud, D., The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas (2007) Gastroenterology, 132 (6), pp. 2208-2225Samanic, C., Gridley, G., Chow, W.H., Lubin, J., Hoover, R.N., Fraumeni Jr., J.F., Obesity and cancer risk among white and black United States veterans (2004) Cancer Causes Control, 15 (1), pp. 35-43Luo, J., Margolis, K.L., Adami, H.O., laCroix, A., Ye, W., Obesity and risk of pancreatic cancer among postmenopausal women: The Women's Health Initiative (United States) (2008) Br J Cancer, 99 (3), pp. 527-531. , Epub 2008 Jul 15Gapstur, S.M., Gann, P.H., Lowe, W., Liu, K., Colangelo, L., Dyer, A., Abnormal glucose metabolism and pancreatic cancer mortality (2000) JAMA, 283 (19), pp. 2552-2558Wolpin, B.M., Michaud, D.S., Giovannucci, E.L., Schernhammer, E.S., Stampfer, M.J., Manson, J.E., Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohort (2007) Br J Cancer, 97 (1), pp. 98-104. , Epub 2007 May 29MacInnis, R.J., English, D.R., Body size and composition and prostate cancer risk: Systematic review and meta-regression analysis (2006) Cancer Causes Control, 17 (8), pp. 989-1003Potischman, N., Swanson, C.A., Siiteri, P., Hoover, R.N., Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status (1996) J Natl Cancer Inst, 88 (11), pp. 756-758Chan, J.M., Stampfer, M.J., Giovannucci, E., Gann, P.H., Ma, J., Wilkinson, P., Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study (1998) Science, 279 (5350), pp. 563-566Larsson, S.C., Wolk, A., Obesity and the risk of gallbladder cancer: A meta-analysis (2007) Br J Cancer, 96 (9), pp. 1457-1461Caldwell, S.H., Crespo, D.M., Kang, H.S., Al-Osaimi, A.M., Obesity and hepatocellular carcinoma (2004) Gastroenterology, 127 (5 SUPPL. 1), pp. S97-S103. , ReviewPan, S.Y., Johnson, K.C., Ugnat, A.M., Wen, S.W., Mao, Y., Association of obesity and cancer risk in Canada (2004) Am J Epidemiol, 159 (3), pp. 259-268Lahmann, P.H., Hoffmann, K., Allen, N., van Gils, C.H., Khaw, K.T., Tehard, B., Body size and breast cancer risk: Findings from the European Prospective Investigation into Cancer and Nutrition (EPIC) (2004) Int J Cancer, 111 (5), pp. 762-771Olsen, C.M., Green, A.C., Whiteman, D.C., Sadeghi, S., Obesity and the risk of epithelial ovarian cancer: A systematic review and meta-analysis (2007) Eur J Cancer, 43 (4), pp. 690-709. , Epub 2007 Jan 12Olsen, C.M., Nagle, C.M., Whiteman, D.C., Purdie, D.M., Green, A.C., Webb, P.M., Body size and risk of epithelial ovarian and related cancers: A population-based case-control study (2008) Int J Cancer, 123 (2), pp. 450-456Engeland, A., Tretli, S., Hansen, S., Bjørge, T., Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women (2007) Am J Epidemiol, 165 (1), pp. 44-52. , Epub 2006 Oct 13Larsson, S.C., Wolk, A., Body mass index and risk of multiple myeloma: A meta-analysis (2007) Int J Cancer, 121 (11), pp. 2512-2516Druker, B.J., Imatinib as a paradigm of targeted therapies (2004) Adv Cancer Res, 91, pp. 1-30McKeown-Eyssen, G., Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? (1994) Cancer Epidemiol Biomarkers Prev, 3 (8), pp. 687-695Giovannucci, E., Insulin and colon cancer (1995) Cancer Causes Control, 6 (2), pp. 164-179. , ReviewGiovannucci, E., Nutrition, insulin, insulin-like growth factors and cancer (2003) Horm Metab Res, 35 (11-12), pp. 694-704Calle, E.E., Kaaks, R., Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms (2004) Nat Rev Cancer, 4 (8), pp. 579-591Allen, N.E., Appleby, P.N., Kaaks, R., Rinaldi, S., Davey, G.K., Key, T.J., Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women (2003) Cancer Causes Control, 14 (1), pp. 65-74Holmes, M.D., Pollak, M.N., Hankinson, S.E., Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations (2002) Cancer Epidemiol Biomarkers Prev, 11 (9), pp. 862-867Myal, Y., Shiu, R.P., Bhaumick, B., Bala, M., Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture (1984) Cancer Res, 44 (12 PART. 1), pp. 5486-5490Wu, Y., Cui, K., Miyoshi, K., Hennighausen, L., Green, J.E., Setser, J., Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors (2003) Cancer Res, 63 (15), pp. 4384-4388Pollak, M., Blouin, M.J., Zhang, J.C., Kopchick, J.J., Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist (2001) Br J Cancer, 85 (3), pp. 428-430Creighton, C.J., Casa, A., Lazard, Z., Huang, S., Tsimelzon, A., Hilsenbeck, S.G., Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis (2008) J Clin Oncol, 26, pp. 4078-4085Carvalheira, J.B., Zecchin, H.G., Saad, M.J., (2002) Arq Bras Endocrinol Metabol, 46 (4), pp. 419-425. , Vias de sinalização da insulinaMoore, T., Beltran, L., Carbajal, S., Strom, S., Traag, J., Hursting, S.D., Dietary energy balance modulates signaling through the akt/mammalian target of rapamycin pathways in multiple epithelial tissues (2008) Cancer Prev Res, 1 (1), pp. 65-76. , Epub 2008 Mar 31Cantley, L.C., The phosphoinositide 3-kinase pathway (2002) Science, 296 (5573), pp. 1655-1657Inoki, K., li, Y., Zhu, T., Wu, J., Guan, K.L., TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (2002) Nat Cell Biol, 4 (9), pp. 648-657Garami, A., Zwartkruis, F.J., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 (2003) Mol Cell, 11 (6), pp. 1457-1466Hay, N., Sonenberg, N., Upstream and downstream of mTOR (2004) Genes Dev, 18 (16), pp. 1926-1945McManus, E.J., Alessi, D.R., TSC1-TSC2: A complex tale of PKB-mediated S6K regulation (2002) Nat Cell Biol, 4 (9), pp. E214-E216Roux, P.P., Ballif, B.A., Anjum, R., Gygi, S.P., Blenis, J., Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase (2004) Proc Natl Acad Sci U S A, 101 (37), pp. 13489-13494. , Epub 2004 Sep 1Inoki, K., Zhu, T., Guan, K.L., TSC2 mediates cellular energy response to control cell growth and survival (2003) Cell, 115 (5), pp. 577-590Harrington, L.S., Findlay, G.M., Lamb, R.F., Restraining PI3K: MTOR signalling goes back to the membrane (2005) Trends Biochem Sci, 30 (1), pp. 35-42Fantl, W.J., Muslin, A.J., Kikuchi, A., Martin, J.A., MacNicol, A.M., Gross, R.W., Activation of Raf-1 by 14-3-3 proteins (1994) Nature, 371 (6498), pp. 612-614Blagosklonny, M.V., Hsp-90-associated oncoproteins: Multiple targets of geldanamycin and its analogs (2002) Leukemia, 16 (4), pp. 455-462Kyriakis, J.M., App, H., Zhang, X.F., Banerjee, P., Brautigan, D.L., Rapp, U.R., Raf-1 activated MAP kinase kinase (1992) Nature, 358 (6385), pp. 417-421Yoon, S., Seger, R., The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions (2006) Growth Factors, 24 (1), pp. 21-44Murphy, L.O., Blenis, J., MAPK signal specificity: The right place at the right time (2006) Trends Biochem Sci, 31 (5), pp. 268-275. , Epub 2006 Apr 17Key, T.J., Appleby, P.N., Reeves, G.K., Roddam, A., Dorgan, J.F., Longcope, C., Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women (2003) J Natl Cancer Inst, 95 (16), pp. 1218-1226Pugeat, M., Crave, J.C., Elmidani, M., Nicolas, M.H., Garoscio-Cholet, M., Lejeune, H., Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin (1991) J Steroid Biochem Mol Biol, 40 (4-6), pp. 841-849McTiernan, A., Rajan, K.B., Tworoger, S.S., Irwin, M., Bernstein, L., Baumgartner, R., Adiposity and sex hormones in postmenopausal breast cancer survivors (2003) J Clin Oncol, 21 (10), pp. 1961-1966Fortunati, N., Fissore, F., Fazzari, A., Piovano, F., Catalano, M.G., Becchis, M., Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG) (1999) J Steroid Biochem Mol Biol, 70 (1-3), pp. 73-80Fortunati, N., Fissore, F., Fazzari, A., Becchis, M., Comba, A., Catalano, M.G., Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3′,5′-monophosphate and protein kinase A (1996) Endocrinology, 137 (2), pp. 686-692Catalano, M.G., Frairia, R., Boccuzzi, G., Fortunati, N., Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells (2005) Mol Cell Endocrinol, 230 (1-2), pp. 31-37Lee, A.V., Jackson, J.G., Gooch, J.L., Hilsenbeck, S.G., Coronado-Heinsohn, E., Osborne, C.K., Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo (1999) Mol Endocrinol, 13 (5), pp. 787-796Dunaif, A., Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis (1997) Endocr Rev, 18 (6), pp. 774-800Ehrmann, D.A., Barnes, R.B., Rosenfield, R.L., Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion (1995) Endocr Rev, 16 (3), pp. 322-353. , ReviewDruckmann, R., Rohr, U.D., IGF-1 in gynaecology and obstetrics: Update 2002 (2002) Maturitas, 41 (SUPPL. 1), pp. S65-S83Colangelo, L.A., Gapstur, S.M., Gann, P.H., Dyer, A.R., Liu, K., Colorectal cancer mortality and factors related to the insulin resistance syndrome (2002) Cancer Epidemiol Biomarkers Prev, 11 (4), pp. 385-391Schiff, R., Massarweh, S.A., Shou, J., Bharwani, L., Mohsin, S.K., Osborne, C.K., Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance (2004) Clin Cancer Res, 10 (1 PART. 2), pp. S331-S336Balkwill, F., Mantovani, A., Inflammation and cancer: Back to Virchow? (2001) Lancet, 357 (9255), pp. 539-545Roder, D.M., The epidemiology of gastric cancer (2002) Gastric Cancer, 5 (SUPPL. 1), pp. 5-11Ekbom, A., Risk of cancer in ulcerative colitis (1998) J Gastrointest Surg, 2 (4), pp. 312-313. , ReviewDhala, A., Pinsker, K., Prezant, D.J., Respiratory health consequences of environmental tobacco smoke (2004) Med Clin North Am, 88 (6), pp. 1535-1552+xiHotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance (1993) Science, 259 (5091), pp. 87-91Tsukumo, D.M., Carvalho-Filho, M.A., Carvalheira, J.B., Prada, P.O., Hirabara, S.M., Schenka, A.A., Loss-of-f

Inactivation of capsaicin-sensitive nerves reduces pulmonary remodeling in guinea pigs with chronic allergic pulmonary inflammation

Pulmonary remodeling is an important feature of asthma physiopathology that can contribute to irreversible changes in lung function. Although neurokinins influence lung inflammation, their exact role in the extracellular matrix (ECM) remodeling remains to be determined. Our objective was to investigate whether inactivation of capsaicin-sensitive nerves modulates pulmonary ECM remodeling in animals with chronic lung inflammation. After 14 days of capsaicin (50 mg/kg, sc) or vehicle administration, male Hartley guinea pigs weighing 250-300 g were submitted to seven inhalations of increasing doses of ovalbumin (1, 2.5, and 5 mg/mL) or saline for 4 weeks. Seventy-two hours after the seventh inhalation, animals were anesthetized and mechanically ventilated and the lung mechanics and collagen and elastic fiber content in the airways, vessels and lung parenchyma were evaluated. Ovalbumin-exposed animals presented increasing collagen and elastic fiber content, respectively, in the airways (9.2 ± 0.9; 13.8 ± 1.2), vessels (19.8 ± 0.8; 13.4 ± 0.5) and lung parenchyma (9.2 ± 0.9; 13.8 ± 1.2) compared to control (P < 0.05). Capsaicin treatment reduced collagen and elastic fibers, respectively, in airways (1.7 ± 1.1; 7.9 ± 1.5), vessels (2.8 ± 1.1; 4.4 ± 1.1) and lung tissue (2.8 ± 1.1; 4.4 ± 1.1) of ovalbumin-exposed animals (P < 0.05). These findings were positively correlated with lung mechanical responses to antigenic challenge (P < 0.05). In conclusion, inactivation of capsaicin-sensitive nerve fibers reduces pulmonary remodeling, particularly collagen and elastic fibers, which contributes to the attenuation of pulmonary functional parameters

Hypothalamic S1p/s1pr1 axis controls energy homeostasis

Sphingosine 1-phosphate receptor 1 (S1PR1) is a G-protein-coupled receptor for sphingosine-1-phosphate (S1P) that has a role in many physiological and pathophysiological processes. Here we show that the S1P/S1PR1 signalling pathway in hypothalamic neurons regulates energy homeostasis in rodents. We demonstrate that S1PR1 protein is highly enriched in hypothalamic POMC neurons of rats. Intracerebroventricular injections of the bioactive lipid, S1P, reduce food consumption and increase rat energy expenditure through persistent activation of STAT3 and the melanocortin system. Similarly, the selective disruption of hypothalamic S1PR1 increases food intake and reduces the respiratory exchange ratio. We further show that STAT3 controls S1PR1 expression in neurons via a positive feedback mechanism. Interestingly, several models of obesity and cancer anorexia display an imbalance of hypothalamic S1P/S1PR1/STAT3 axis, whereas pharmacological intervention ameliorates these phenotypes. Taken together, our data demonstrate that the neuronal S1P/S1PR1/STAT3 signalling axis plays a critical role in the control of energy homeostasis in rats.Sphingosine 1-phosphate receptor 1 (S1PR1) is a G-protein-coupled receptor for sphingosine-1-phosphate (S1P) that has a role in many physiological and pathophysiological processes. Here we show that the S1P/S1PR1 signalling pathway in hypothalamic neurons regulates energy homeostasis in rodents. We demonstrate that S1PR1 protein is highly enriched in hypothalamic POMC neurons of rats. Intracerebroventricular injections of the bioactive lipid, S1P, reduce food consumption and increase rat energy expenditure through persistent activation of STAT3 and the melanocortin system. Similarly, the selective disruption of hypothalamic S1PR1 increases food intake and reduces the respiratory exchange ratio. We further show that STAT3 controls S1PR1 expression in neurons via a positive feedback mechanism. Interestingly, several models of obesity and cancer anorexia display an imbalance of hypothalamic S1P/S1PR1/STAT3 axis, whereas pharmacological intervention ameliorates these phenotypes. Taken together, our data demonstrate that the neuronal S1P/S1PR1/STAT3 signalling axis plays a critical role in the control of energy homeostasis in rats5485

Hypothalamic S1p/s1pr1 Axis Controls Energy Homeostasis

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Sphingosine 1-phosphate receptor 1 (S1PR1) is a G-protein-coupled receptor for sphingosine-1-phosphate (S1P) that has a role in many physiological and pathophysiological processes. Here we show that the S1P/S1PR1 signalling pathway in hypothalamic neurons regulates energy homeostasis in rodents. We demonstrate that S1PR1 protein is highly enriched in hypothalamic POMC neurons of rats. Intracerebroventricular injections of the bioactive lipid, S1P, reduce food consumption and increase rat energy expenditure through persistent activation of STAT3 and the melanocortin system. Similarly, the selective disruption of hypothalamic S1PR1 increases food intake and reduces the respiratory exchange ratio. We further show that STAT3 controls S1PR1 expression in neurons via a positive feedback mechanism. Interestingly, several models of obesity and cancer anorexia display an imbalance of hypothalamic S1P/S1PR1/STAT3 axis, whereas pharmacological intervention ameliorates these phenotypes. Taken together, our data demonstrate that the neuronal S1P/S1PR1/STAT3 signalling axis plays a critical role in the control of energy homeostasis in rats.5Capes-12900-13-3; CAPES; Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Schwartz, M.W., Woods, S.C., Porte, D., Jr., Seeley, R.J., Baskin, D.G., Central nervous system control of food intake (2000) Nature, 404, pp. 661-671Munzberg, H., Huo, L., Nillni, E.A., Hollenberg, A.N., Bjorbaek, C., Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin (2003) Endocrinology, 144, pp. 2121-2131Myers, M.G., Cowley, M.A., Munzberg, H., Mechanisms of leptin action and leptin resistance (2008) Annu. Rev. Physiol., 70, pp. 537-556Janoschek, R., Gp130 signaling in proopiomelanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor (2006) Proc. Natl Acad. Sci. USA, 103, pp. 10707-10712Johnen, H., Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1 (2007) Nat. Med., 13, pp. 1333-1340Ropelle, E.R., IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition (2010) PLoS Biol., 8El-Haschimi, K., Pierroz, D.D., Hileman, S.M., Bjorbaek, C., Flier, J.S., Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity (2000) J. Clin. Invest., 105, pp. 1827-1832Ernst, M.B., Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity (2009) J. Neurosci., 29, pp. 11582-11593Gao, Q., Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals (2007) Nat. Med., 13, pp. 89-94Ghilardi, N., Defective STAT signaling by the leptin receptor in diabetic mice (1996) Proc. Natl Acad. Sci. USA, 93, pp. 6231-6235Frias, M.A., James, R.W., Gerber-Wicht, C., Lang, U., Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: Role of sphingosine-1-phosphate (2009) Cardiovasc. Res., 82, pp. 313-323Gurgui, M., Broere, R., Kalff, J.C., Van Echten-Deckert, G., Dual action of sphingosine 1-phosphate in eliciting proinflammatory responses in primary cultured rat intestinal smooth muscle cells (2010) Cell Signal., 22, pp. 1727-1733Lee, H., STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors (2010) Nat. Med., 16, pp. 1421-1428Liang, J., Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer (2013) Cancer Cell, 23, pp. 107-120Spiegel, S., Milstien, S., The outs and the ins of sphingosine-1-phosphate in immunity (2011) Nat. Rev. Immunol., 11, pp. 403-415Spiegel, S., Milstien, S., Functions of the multifaceted family of sphingosine kinases and some close relatives (2007) J. Biol. Chem., 282, pp. 2125-2129Loh, K.C., Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway (2012) PLoS One, 7Lopez, M., Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin (2008) Cell. Metab., 7, pp. 389-399Oo, M.L., Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice (2011) J. Clin. Invest., 121, pp. 2290-2300Means, C.K., Brown, J.H., Sphingosine-1-phosphate receptor signalling in the heart (2009) Cardiovasc. Res., 82, pp. 193-200Schwartz, M.W., Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus (1997) Diabetes, 46, pp. 2119-2123Cowley, M.A., Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus (2001) Nature, 411, pp. 480-484Bates, S.H., STAT3 signalling is required for leptin regulation of energy balance but not reproduction (2003) Nature, 421, pp. 856-859Mynard, V., Guignat, L., Devin-Leclerc, J., Bertagna, X., Catelli, M.G., Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions (2002) Endocrinology, 143, pp. 3916-3924Bousquet, C., Zatelli, M.C., Melmed, S., Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immunoneuroendocrine interfacing (2000) J. Clin. Invest., 106, pp. 1417-1425Bousquet, C., Melmed, S., Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling (1999) J. Biol. Chem., 274, pp. 10723-10730Andreux, P.A., Systems genetics of metabolism: The use of the BXD murine reference panel for multiscalar integration of traits (2012) Cell, 150, pp. 1287-1299Guissouma, H., Froidevaux, M.S., Hassani, Z., Demeneix, B.A., In vivo siRNA delivery to the mouse hypothalamus confirms distinct roles of TR beta isoforms in regulating TRH transcription (2006) Neurosci. Lett., 406, pp. 240-243Froidevaux, M.S., The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo (2006) EMBO Rep., 7, pp. 1035-1039Nagahashi, M., Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis (2012) Cancer Res., 72, pp. 726-735Brinkmann, V., Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis (2010) Nat. Rev. Drug Discov., 9, pp. 883-897Graler, M.H., Goetzl, E.J., The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors (2004) FASEB J., 18, pp. 551-553Guo, H., An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway (2013) J. Neurosci., 33, pp. 6181-6190Ishii, I., Fukushima, N., Ye, X., Chun, J., Lysophospholipid receptors: Signaling and biology (2004) Annu. Rev. Biochem., 73, pp. 321-354Walter, D.H., Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor (2007) Arterioscler. Thromb. Vasc. Biol., 27, pp. 275-282Grossberg, A.J., Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130 (2010) Endocrinology, 151, pp. 606-616Febbraio, M.A., Gp130 receptor ligands as potential therapeutic targets for obesity (2007) J. Clin. Invest., 117, pp. 841-849Samad, F., Hester, K.D., Yang, G., Hannun, Y.A., Bielawski, J., Altered adipose and plasma sphingolipid metabolism in obesity: A potential mechanism for cardiovascular and metabolic risk (2006) Diabetes, 55, pp. 2579-2587Bence, K.K., Neuronal PTP1B regulates body weight, adiposity and leptin action (2006) Nat. Med., 12, pp. 917-924Chiarreotto-Ropelle, E.C., Acute exercise suppresses hypothalamic PTP1B protein level and improves insulin and leptin signaling in obese rats (2013) Am. J. Physiol. Endocrinol. Metab., 305, pp. E649-E659Picardi, P.K., Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats (2008) Endocrinology, 149, pp. 3870-3880Milanski, M., Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: Implications for the pathogenesis of obesity (2009) J. Neurosci., 29, pp. 359-370Purkayastha, S., Zhang, G., Cai, D., Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappaB (2011) Nat. Med., 17, pp. 883-887Zhang, X., Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity (2008) Cell, 135, pp. 61-73Laviano, A., Meguid, M.M., Rossi-Fanelli, F., Cancer anorexia: Clinical implications, pathogenesis, and therapeutic strategies (2003) Lancet Oncol., 4, pp. 686-694Tisdale, M.J., Biology of cachexia (1997) J. Natl Cancer Inst., 89, pp. 1763-1773Pchejetski, D., Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer (2010) Breast Cancer Res. Treat., 124, pp. 543-549Ponnusamy, S., Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis (2012) EMBO Mol. Med., 4, pp. 761-775Mellon, P.L., Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis (1990) Neuron, 5, pp. 1-1

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

The Role Of Neuronal Ampk As A Mediator Of Nutritional Regulation Of Food Intake And Energy Homeostasis

Hypothalamic 5′-adenosine monophosphate-activated protein kinase (AMPK) senses intracellular metabolic stress, i.e., an increase in the cellular AMP:ATP ratio, and integrates diverse hormonal and nutritional signals to restore energy balance. Recent evidence suggests that different nutrients can modulate AMPK activity in the hypothalamus, thereby controlling weight gain through a leptin-independent mechanism. Understanding the mechanisms by which nutrients control hypothalamic AMPK activity is crucial to the development of effective nutritional interventions for the treatment of food intake-related disorders, such as anorexia and obesity. This article highlights the current evidence for the intricate relationship between nutrients and hypothalamic AMPK activity. © 2013 Elsevier Inc.622171178Flegal, K.M., Graubard, B.I., Williamson, D.F., Gail, M.H., Excess deaths associated with underweight, overweight, and obesity (2005) Journal of the American Medical Association, 293 (15), pp. 1861-1867. , DOI 10.1001/jama.293.15.1861Fearon, K., Strasser, F., Anker, S.D., Definition and classification of cancer cachexia: An international consensus (2011) Lancet Oncol, 12, pp. 489-495Pauling, L., Evolution and the need for ascorbic acid (1970) Proc Natl Acad Sci U S A, 67, pp. 1643-1648Cameron, E., Pauling, L., Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases (1973) Oncology, 27, pp. 181-192Pauling, L., Alcantara, E.N., Speckmann, E.W., Diet, nutrition, and cancer (1977) American Journal of Clinical Nutrition, 30 (5), pp. 661-663A critique of low-carbohydrate ketogenic weight reduction regimens. A review of Dr. Atkins' diet revolution (1973) JAMA, 224, pp. 1415-1419Gardner, C.D., Kiazand, A., Alhassan, S., Kim, S., Stafford, R.S., Balise, R.R., Kraemer, H.C., King, A.C., Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: The A to Z weight loss study: A randomized trial (2007) Journal of the American Medical Association, 297 (9), pp. 969-977. , http://jama.ama-assn.org/cgi/reprint/297/9/969, DOI 10.1001/jama.297.9.969Schwartz, M.W., Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity (2001) Journal of Clinical Investigation, 108 (7), pp. 963-964. , DOI 10.1172/JCI200114127Morton, G.J., Cummings, D.E., Baskin, D.G., Barsh, G.S., Schwartz, M.W., Central nervous system control of food intake and body weight (2006) Nature, 443 (7109), pp. 289-295. , DOI 10.1038/nature05026, PII NATURE05026Woods, A., Cheung, P.C., Smith, F.C., Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro (1996) J Biol Chem, 271, pp. 10282-10290Dhillo, W.S., Appetite regulation: An overview (2007) Thyroid, 17 (5), pp. 433-445. , DOI 10.1089/thy.2007.0018Ropelle, E.R., Pauli, J.R., Zecchin, K.G., Ueno, M., De Souza, C.T., Morari, J., Faria, M.C., Carvalheira, J.B.C., A central role for neuronal adenosine 5′-monophosphate-activated protein kinase in cancer-induced anorexia (2007) Endocrinology, 148 (11), pp. 5220-5229. , http://endo.endojournals.org/cgi/reprint/148/11/5220, DOI 10.1210/en.2007-0381Carvalheira, J.B.C., Ribeiro, E.B., Araujo, E.P., Guimaraes, R.B., Telles, M.M., Torsoni, M., Gontijo, J.A.R., Saad, M.J.A., Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats (2003) Diabetologia, 46 (12), pp. 1629-1640. , DOI 10.1007/s00125-003-1246-xRopelle, E.R., Fernandes, M.F., Flores, M.B., Central exercise action increases the AMPK and mTOR response to leptin (2008) PLoS One, 3, p. 3856Ropelle, E.R., Pauli, J.R., Fernandes, M.F., A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss (2008) Diabetes, 57, pp. 594-605Ropelle, E.R., Pauli, J.R., Prada, P., Inhibition of hypothalamic Foxo1 expression reduced food intake in diet-induced obesity rats (2009) J Physiol, 587, pp. 2341-2351Ropelle, E.R., Flores, M.B., Cintra, D.E., IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition (2010) PLoS Biol, 8, p. 1000465Pimentel, G.D., Lira, F.S., Rosa, J.C., Intake of trans fatty acids during gestation and lactation leads to hypothalamic inflammation via TLR4/NFkappaBp65 signaling in adult offspring (2012) J Nutr Biochem, 23, pp. 265-271Xue, B., Kahn, B.B., AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues (2006) Journal of Physiology, 574 (1), pp. 73-83. , DOI 10.1113/jphysiol.2006.113217Minokoshi, Y., Alquier, T., Furukawa, H., Kim, Y.-B., Lee, A., Xue, B., Mu, J., Kahn, B.B., AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus (2004) Nature, 428 (6982), pp. 569-574. , DOI 10.1038/nature02440Kahn, B.B., Alquier, T., Carling, D., Hardie, D.G., AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism (2005) Cell Metabolism, 1 (1), pp. 15-25. , DOI 10.1016/j.cmet.2004.12.003, PII S1550413104000099Cota, D., Proulx, K., Blake Smith, K.A., Kozma, S.C., Thomas, G., Woods, S.C., Seeley, R.J., Hypothalamic mTOR signaling regulates food intake (2006) Science, 312 (5775), pp. 927-930. , DOI 10.1126/science.1124147Lage, R., Dieguez, C., Vidal-Puig, A., AMPK: A metabolic gauge regulating whole-body energy homeostasis (2008) Trends Mol Med, 14, pp. 539-549Kola, B., Hubina, E., Tucci, S.A., Kirkham, T.C., Garcia, E.A., Mitchell, S.E., Williams, L.M., Korbonits, M., Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase (2005) Journal of Biological Chemistry, 280 (26), pp. 25196-25201. , DOI 10.1074/jbc.C500175200Claret, M., Smith, M.A., Batterham, R.L., Selman, C., Choudhury, A.I., Fryer, L.G.D., Clements, M., Withers, D.J., AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons (2007) Journal of Clinical Investigation, 117 (8), pp. 2325-2336. , http://www.jci.org/cgi/reprint/117/8/2325, DOI 10.1172/JCI31516Lopez, M., Lage, R., Saha, A.K., Perez-Tilve, D., Vazquez, M.J., Varela, L., Sangiao-Alvarellos, S., Vidal-Puig, A., Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin (2008) Cell Metabolism, 7 (5), pp. 389-399. , DOI 10.1016/j.cmet.2008.03.006, PII S1550413108000776Lopez, M., Varela, L., Vazquez, M.J., Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance (2010) Nat Med, 16, pp. 1001-1008Claret, M., Smith, M.A., Knauf, C., Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in mice (2011) Diabetes, 60, pp. 735-745Carling, D., Hardie, D.G., The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase (1989) Biochimica et Biophysica Acta - Molecular Cell Research, 1012 (1), pp. 81-86. , DOI 10.1016/0167-4889(89)90014-1Beg, Z.H., Allmann, D.W., Gibson, D.M., Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and wth protein fractions of rat liver cytosol (1973) Biochem Biophys Res Commun, 54, pp. 1362-1369Carlson, C.A., Kim, K.H., Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation (1973) J Biol Chem, 248, pp. 378-380Hardie, D.G., The AMP-activated protein kinase pathway - New players upstream and downstream (2004) Journal of Cell Science, 117 (23), pp. 5479-5487. , DOI 10.1242/jcs.01540Minokoshi, Y., Kim, Y.-B., Peroni, O.D., Fryer, L.G.D., Muller, C., Carling, D., Kahn, B.B., Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase (2002) Nature, 415 (6869), pp. 339-343. , DOI 10.1038/415339aKubota, N., Yano, W., Kubota, T., Yamauchi, T., Itoh, S., Kumagai, H., Kozono, H., Kadowaki, T., Adiponectin stimulates amp-activated protein kinase in the hypothalamus and increases food intake (2007) Cell Metabolism, 6 (1), pp. 55-68. , DOI 10.1016/j.cmet.2007.06.003, PII S1550413107001593Hayes, M.R., Bradley, L., Grill, H.J., Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling (2009) Endocrinology, 150, pp. 2654-2659Andersson, U., Filipsson, K., Abbott, C.R., Woods, A., Smith, K., Bloom, S.R., Carling, D., Small, C.J., AMP-activated Protein Kinase Plays a Role in the Control of Food Intake (2004) Journal of Biological Chemistry, 279 (13), pp. 12005-12008. , DOI 10.1074/jbc.C300557200Obici, S., Feng, Z., Arduini, A., Conti, R., Rossetti, L., Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production (2003) Nature Medicine, 9 (6), pp. 756-761. , DOI 10.1038/nm873Loftus, T.M., Jaworsky, D.E., Frehywot, C.L., Townsend, C.A., Ronnett, G.V., Daniel Lane, M., Kuhajda, F.P., Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors (2000) Science, 288 (5475), pp. 2379-2381. , DOI 10.1126/science.288.5475.2379Blouet, C., Jo, Y.H., Li, X., Schwartz, G.J., Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus-brainstem circuit (2009) J Neurosci, 29, pp. 8302-8311Chau-Van, C., Gamba, M., Salvi, R., Gaillard, R.C., Pralong, F.P., Metformin inhibits adenosine 5′-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons (2007) Endocrinology, 148 (2), pp. 507-511. , http://endo.endojournals.org/cgi/reprint/148/2/507, DOI 10.1210/en.2006-1237Kim, Y.W., Kim, J.Y., Park, Y.H., Metformin restores leptin sensitivity in high-fat-fed obese rats with leptin resistance (2006) Diabetes, 55, pp. 716-724Dansinger, M.L., Gleason, J.A., Griffith, J.L., Selker, H.P., Schaefer, E.J., Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for weight loss and heart disease risk reduction: A randomized trial (2005) Journal of the American Medical Association, 293 (1), pp. 43-53. , DOI 10.1001/jama.293.1.43Shigemitsu, K., Tsujishita, Y., Miyake, H., Hidayat, S., Tanaka, N., Hara, K., Yonezawa, K., Structural requirement of leucine for activation of p70 S6 kinase (1999) FEBS Letters, 447 (2-3), pp. 303-306. , DOI 10.1016/S0014-5793(99)00304-X, PII S001457939900304XTome, D., Schwarz, J., Darcel, N., Protein, amino acids, vagus nerve signaling, and the brain (2009) Am J Clin Nutr, 90, pp. 838S-843SPurpera, M.N., Shen, L., Taghavi, M., Impaired branched chain amino acid metabolism alters feeding behavior and increases orexigenic neuropeptide expression in the hypothalamus (2012) J Endocrinol, 212, pp. 85-94Catania, C., Binder, E., Cota, D., MTORC1 signaling in energy balance and metabolic disease (2011) Int J Obes (Lond), 35, pp. 751-761Cota, D., Matter, E.K., Woods, S.C., The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity (2008) J Neurosci, 28, pp. 7202-7208Xu, G., Kwon, G., Cruz, W.S., Marshall, C.A., McDaniel, M.L., Metabolic regulation by leucine of translation initiation through the mTOR-signaling pathway by pancreatic β-cells (2001) Diabetes, 50 (2), pp. 353-360Fujita, S., Dreyer, H.C., Drummond, M.J., Glynn, E.L., Cadenas, J.G., Yoshizawa, F., Volpi, E., Rasmussen, B.B., Nutrient signalling in the regulation of human muscle protein synthesis (2007) Journal of Physiology, 582 (2), pp. 813-823. , DOI 10.1113/jphysiol.2007.134593Wilson, G.J., Layman, D.K., Moulton, C.J., Leucine or carbohydrate supplementation reduces AMPK and eEF2 phosphorylation and extends postprandial muscle protein synthesis in rats (2011) Am J Physiol Endocrinol Metab, 301, pp. 1236-E1242Du, M., Shen, Q.W., Zhu, M.J., Ford, S.P., Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase (2007) Journal of Animal Science, 85 (4), pp. 919-927. , DOI 10.2527/jas.2006-342Aftring, R.P., Block, K.P., Buse, M.G., Leucine and isoleucine activate skeletal muscle branched-chain alpha-keto acid dehydrogenase in vivo (1986) Am J Physiol, 250, pp. 599-E604Mayer, J., Regulation of energy intake and the body weight: The glucostatic theory and the lipostatic hypothesis (1955) Ann N y Acad Sci, 63, pp. 15-43Anand, B.K., Chhina, G.S., Sharma, K.N., Activity of single neurons in the hypothalamic feeding centers: Effect of glucose (1964) Am J Physiol, 207, pp. 1146-1154Oomura, Y., Kimura, K., Ooyama, H., Reciprocal activities of the ventromedial and lateral hypothalamic areas of cats (1964) Science, 143, pp. 484-485Mizuno, Y., Oomura, Y., Glucose responding neurons in the nucleus tractus solitarius of the rat: In vitro study (1984) Brain Research, 307 (1-2), pp. 109-116Nakano, Y., Oomura, Y., Lenard, L., Feeding-related activity of glucose- and morphine-sensitive neurons in the monkey amygdala (1986) Brain Research, 399 (1), pp. 167-172. , DOI 10.1016/0006-8993(86)90613-XCha, S.H., Wolfgang, M., Tokutake, Y., Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake (2008) Proc Natl Acad Sci U S A, 105, pp. 16871-16875Kim, M.-S., Park, J.-Y., Namkoong, C., Jang, P.-G., Ryu, J.-W., Song, H.-S., Yun, J.-Y., Lee, K.-U., Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase (2004) Nature Medicine, 10 (7), pp. 727-733. , DOI 10.1038/nm1061Wolfgang, M.J., Cha, S.H., Sidhaye, A., Regulation of hypothalamic malonyl-CoA by central glucose and leptin (2007) Proc Natl Acad Sci U S A, 104, pp. 19285-19290Lee, K., Li, B., Xi, X., Suh, Y., Martin, R.J., Role of neuronal energy status in the regulation of adenosine 5′-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior (2005) Endocrinology, 146 (1), pp. 3-10. , DOI 10.1210/en.2004-0968Cai, F., Gyulkhandanyan, A.V., Wheeler, M.B., Belsham, D.D., Glucose regulates AMP-activated protein kinase activity and gene expression in clonal, hypothalamic neurons expressing proopiomelanocortin: Additive effects of leptin or insulin (2007) Journal of Endocrinology, 192 (3), pp. 605-614. , DOI 10.1677/JOE-06-0080Zhang, H., Zhang, G., Gonzalez, F.J., Hypoxia-inducible factor directs POMC gene to mediate hypothalamic glucose sensing and energy balance regulation (2011) PLoS Biol, 9, p. 1001112De Souza, C.T., Araujo, E.P., Bordin, S., Ashimine, R., Zollner, R.L., Boschero, A.C., Saad, M.J.A., Velloso, L.A., Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus (2005) Endocrinology, 146 (10), pp. 4192-4199. , http://endo.endojournals.org/cgi/reprint/146/10/4192, DOI 10.1210/en.2004-1520Zhang, X., Zhang, G., Zhang, H., Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity (2008) Cell, 135, pp. 61-73Posey, K.A., Clegg, D.J., Printz, R.L., Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet (2009) Am J Physiol Endocrinol Metab, 296, pp. 1003-E1012Benoit, S.C., Kemp, C.J., Elias, C.F., Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents (2009) J Clin Invest, 119, pp. 2577-2589Tsukumo, D.M.L., Carvalho-Filho, M.A., Carvalheira, J.B.C., Prada, P.O., Hirabara, S.M., Schenka, A.A., Araujo, E.P., Saad, M.J.A., Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance (2007) Diabetes, 56 (8), pp. 1986-1998. , http://diabetes.diabetesjournals.org/cgi/reprint/56/8/1986, DOI 10.2337/db06-1595Lumeng, C.N., Saltiel, A.R., Inflammatory links between obesity and metabolic disease (2011) J Clin Invest, 121, pp. 2111-2117Watts, C., Location, location, location: Identifying the neighborhoods of LPS signaling (2008) Nature Immunology, 9 (4), pp. 343-345. , DOI 10.1038/ni0408-343, PII NI0408-343Horng, T., Barton, G.M., Medzhitov, R., TIRAP: An adapter molecule in the Toll signaling pathway (2001) Nat Immunol, 2, pp. 835-841Martin, T.L., Alquier, T., Asakura, K., Furukawa, N., Preitner, F., Kahn, B.B., Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle (2006) Journal of Biological Chemistry, 281 (28), pp. 18933-18941. , http://www.jbc.org/cgi/reprint/281/28/18933, DOI 10.1074/jbc.M512831200Obici, S., Feng, Z., Morgan, K., Stein, D., Karkanias, G., Rossetti, L., Central administration of oleic acid inhibits glucose production and food intake (2002) Diabetes, 51 (2), pp. 271-275Jo, Y.H., Su, Y., Gutierrez-Juarez, R., Oleic acid directly regulates POMC neuron excitability in the hypothalamus (2009) J Neurophysiol, 101, pp. 2305-2316Schwinkendorf, D.R., Tsatsos, N.G., Gosnell, B.A., Effects of central administration of distinct fatty acids on hypothalamic neuropeptide expression and energy metabolism (2011) Int J Obes (Lond), 35, pp. 336-344Jia, M., Xue, N., Cao, Z., Effects of dietary different ratios of n-3 to n-6 polyunsaturated fatty acids influence lipid metabolism and appetite of rats (2009) Wei Sheng Yan Jiu, 38, pp. 175-178Gomez-Pinilla, F., Ying, Z., Differential effects of exercise and dietary docosahexaenoic acid on molecular systems associated with control of allostasis in the hypothalamus and hippocampus (2010) Neuroscience, 168, pp. 130-137Wallace, R.J., McKain, N., Shingfield, K.J., Devillard, E., Isomers of conjugated linoleic acids are synthesized via different mechanisms in ruminal digesta and bacteria (2007) Journal of Lipid Research, 48 (10), pp. 2247-2254. , http://www.jlr.org/cgi/reprint/48/10/2247, DOI 10.1194/jlr.M700271-JLR200Pariza, M.W., Park, Y., Cook, M.E., The biologically active isomers of conjugated linoleic acid (2001) Progress in Lipid Research, 40 (4), pp. 283-298. , DOI 10.1016/S0163-7827(01)00008-X, PII S016378270100008XPariza, M.W., Perspective on the safety and effectiveness of conjugated linoleic acid (2004) Am J Clin Nutr, 79, pp. 1132S-1136SJiang, S., Wang, Z., Riethoven, J.J., Conjugated linoleic acid activates AMP-activated protein kinase and reduces adiposity more effectively when used with metformin in mice (2009) J Nutr, 139, pp. 2244-2251Miner, J.L., Cederberg, C.A., Nielsen, M.K., Chen, X., Baile, C.A., Conjugated linoleic acid (CLA), body fat, and apoptosis (2001) Obesity Research, 9 (2), pp. 129-134Park, Y., Storkson, J.M., Albright, K.J., Liu, W., Pariza, M.W., Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice (1999) Lipids, 34 (3), pp. 235-241Cao, Z.-P., Wang, F., Xiang, X.-S., Cao, R., Zhang, W.-B., Gao, S.-B., Intracerebroventricular administration of conjugated linoleic acid (CLA) inhibits food intake by decreasing gene expression of NPY and AgRP (2007) Neuroscience Letters, 418 (3), pp. 217-221. , DOI 10.1016/j.neulet.2007.03.010, PII S0304394007002947So, M.H., Tse, I.M., Li, E.T., Dietary fat concentration influences the effects of trans-10, cis-12 conjugated linoleic acid on temporal patterns of energy intake and hypothalamic expression of appetite-controlling genes in mice (2009) J Nutr, 139, pp. 145-151Carreau, J.P., Biosynthesis of lipoic acid via unsaturated fatty acids (1979) Methods Enzymol, 62, pp. 152-158Reed, L.J., A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes (2001) J Biol Chem, 276, pp. 38329-38336Liu, J., The effects and mechanisms of mitochondrial nutrient α-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: An overview (2008) Neurochemical Research, 33 (1), pp. 194-203. , DOI 10.1007/s11064-007-9403-0El Midaoui, A., Elimadi, A., Wu, L., Haddad, P.S., De Champlain, J., Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production (2003) American Journal of Hypertension, 16 (3), pp. 173-179. , DOI 10.1016/S0895-7061(02)03253-3, PII S0895706102032533Targonsky, E.D., Dai, F., Koshkin, V., Karaman, G.T., Gyulkhandanyan, A.V., Zhang, Y., Chan, C.B., Wheeler, M.B., Lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells (2006) Diabetologia, 49 (7), pp. 1587-1598. , DOI 10.1007/s00125-006-0265-9Zhang, Y., Han, P., Wu, N., Amelioration of lipid abnormalities by alpha-lipoic acid through antioxidative and anti-inflammatory effects (2011) Obesity (Silver Spring), 19, pp. 1647-1653Turnley, A.M., Stapleton, D., Mann, R.J., Witters, L.A., Kemp, B.E., Bartlett, P.F., Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system (1999) Journal of Neurochemistry, 72 (4), pp. 1707-1716. , DOI 10.1046/j.1471-4159.1999.721707.xCheng, P.Y., Lee, Y.M., Yen, M.H., Reciprocal effects of alpha-lipoic acid on adenosine monophosphate- activated protein kinase activity in obesity induced by ovariectomy in rats (2011) Menopause, 18, pp. 1010-1017Zhou, J., Zhou, S., Tang, J., Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats (2009) Eur J Pharmacol, 606, pp. 262-268Hur, J.M., Hyun, M.S., Lim, S.Y., The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells (2009) J Cell Biochem, 107, pp. 955-964Wang, J.M., Yang, Z., Xu, M.G., Berberine-induced decline in circulating CD31 +/CD42- microparticles is associated with improvement of endothelial function in humans (2009) Eur J Pharmacol, 614, pp. 77-83Wang, X., Wang, R., Xing, D., Su, H., Ding, Y., D

Urothelial carcinogen resistance driven by stronger toll-like receptor 2 (TLR2) and uroplakin III (UP III) defense mechanisms: a new model

Objective The objective of the study was to illustrate the applicability and significance of the novel Lewis urothelial cancer model compared to the classic Fisher 344. Methods Fischer 344 and Lewis females rats, 7 weeks old, were intravesical instilled N-methyl-N-nitrosourea 1.5 mg/kg every other week for a total of four doses. After 15 weeks, animals were sacrificed and bladders analyzed: histopathology (tumor grade and stage), immunohistochemistry (apoptotic and proliferative indices) and blotting (Toll-like receptor 2-TLR2, Uroplakin III-UP III and C-Myc). Control groups received placebo. Results There were macroscopic neoplastic lesions in 20 % of Lewis strain and 70 % of Fischer 344 strain. Lewis showed hyperplasia in 50 % of animals, normal bladders in 50 %. All Fischer 344 had lesions, 20 % papillary hyperplasia, 30 % dysplasia, 40 % neoplasia and 10 % squamous metaplasia. Proliferative and apoptotic indices were significantly lower in the Lewis strain (p < 0.01). The TLR2 and UP III protein levels were significantly higher in Lewis compared to Fischer 344 strain (70.8 and 46.5 % vs. 49.5 and 16.9 %, respectively). In contrast, C-Myc protein levels were significantly higher in Fischer 344 (22.5 %) compared to Lewis strain (13.7 %). Conclusions The innovative Lewis carcinogen resistance urothelial model represents a new strategy for translational research. Preservation of TLR2 and UP III defense mechanisms might drive diverse urothelial phenotypes during carcinogenesis in differently susceptible individuals. © 2014 Springer-Verlag Berlin Heidelberg.The objective of the study was to illustrate the applicability and significance of the novel Lewis urothelial cancer model compared to the classic Fisher 344. Methods Fischer 344 and Lewis females rats, 7 weeks old, were intravesical instilled N-methyl-N-333413419sem informaçãosem informaçã

Rapport d'activités du programme recherche développement mené dans 6 groupements (Mai-décembre 1992). Résultats et propositions pour la poursuite du programme

Ce document rend compte des activités de recherche developpement initiées par l'ARAF dans 6 groupements depuis Mai 92 avec l'appui de l'ISRA (Kaolack). Les objectifs du programme sont : - de tester avec les groupements des techniques simples répondant à des problèmes soulevés par les paysans; - de sensibiliser et d'informer les producteurs, rarement touchés par des opérations de vulgarisation ou de formation; - d'initier au sein de l'ARAF une dynamique de recherche developpement avec quelques animateurs villageois et de secteurs formés pour cela. Le présent document présentera les différentes actions entreprises en 1992 au niveau de 6 groupements, les résultats qui en découlent ainsi que des recommandations pour la poursuite de ce programme pour les années à veni

O programa de saúde escolar no município de Ribeirão Preto El programa de salud escolar en el municipio de Ribeirão Preto The primary school health care program at the municipality of Ribeirão Preto

O presente artigo relata a trajetória do Programa de Assistência Primária de Saúde Escolar (PROASE) no município de Ribeirão Preto e traz algumas reflexões sobre esta proposta.<br>El presente estudio relata el trayecto del Programa de Atención Primaria de Salud Escolar (PROASE) en el municipio de Ribeirão Preto y trae algunas reflexiones sobre esta propuesta.<br>The present article reports on the trajectory of the Primary School Health Care Program (PROASE) at the municipality of Ribeirão Preto and describes some reflections about this proposal